Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: United Kingdom Clear all

157 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20027
20037
20047
20056
20068
200711
20087
200910
20102
201111
20126
20139
20148
20159
20165
20175
20182
20193
20206
20213
20222
20231
20246
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100
Terminated22
Active, not recruiting15
Unknown status11
Recruiting7
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche16
AstraZeneca10
Pfizer10
GlaxoSmithKline8
Novartis Pharmaceuticals8
Royal Marsden NHS Foundation Trust8
Bayer6
European Organisation for Research and Treatment of Cancer - EORTC6
Institute of Cancer Research, United Kingdom6
Genentech, Inc.5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms157
Neoplasm Metastasis17
Neoplasms8
Triple Negative Breast Neoplasms8
Ovarian Neoplasms7
Prostatic Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms4
Melanoma4
Pancreatic Neoplasms4

Trials

Showing 1 to 25 of 157. Each trial links to its page on Pharma Observatory.

57 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.